Literature DB >> 9192642

A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1.

M A McDevitt1, R A Shivdasani, Y Fujiwara, H Yang, S H Orkin.   

Abstract

The hematopoietic-restricted transcription factor GATA-1 is required for both mammalian erythroid cell and megakaryocyte differentiation. To define the mechanisms governing its transcriptional regulation, we replaced upstream sequences including a DNase I hypersensitive (HS) region with a neomycin-resistance cassette by homologous recombination in mouse embryonic stem cells and generated mice either harboring this mutation (neoDeltaHS) or lacking the selection cassette (DeltaneoDeltaHS). Studies of the consequences of these targeted mutations provide novel insights into GATA-1 function in erythroid cells. First, the neoDeltaHS mutation leads to a marked impairment in the rate or efficiency of erythroid cell maturation due to a modest (4- to 5-fold) decrease in GATA-1 expression. Hence, erythroid differentiation is dose-dependent with respect to GATA-1. Second, since expression of GATA-1 from the DeltaneoDeltaHS allele in erythroid cells is largely restored, transcription interference imposed by the introduced cassette must account for the "knockdown" effect of the mutation. Finally, despite the potency of the upstream sequences in conferring high-level, developmentally appropriate expression of transgenes in mice, other cis-regulatory elements within the GATA-1 compensate for its absence in erythroid cells. Our work illustrates the usefulness of targeted mutations to create knockdown mutations that may uncover important quantitative contributions of gene function not revealed by conventional knockouts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192642      PMCID: PMC21235          DOI: 10.1073/pnas.94.13.6781

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Transcriptional activation and DNA binding by the erythroid factor GF-1/NF-E1/Eryf 1.

Authors:  D I Martin; S H Orkin
Journal:  Genes Dev       Date:  1990-11       Impact factor: 11.361

2.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells.

Authors:  N C Andrews; D V Faller
Journal:  Nucleic Acids Res       Date:  1991-05-11       Impact factor: 16.971

3.  Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter.

Authors:  S F Tsai; E Strauss; S H Orkin
Journal:  Genes Dev       Date:  1991-06       Impact factor: 11.361

Review 4.  GATA-binding transcription factors in hematopoietic cells.

Authors:  S H Orkin
Journal:  Blood       Date:  1992-08-01       Impact factor: 22.113

5.  trans-Activation of a globin promoter in nonerythroid cells.

Authors:  T Evans; G Felsenfeld
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

6.  Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region.

Authors:  C G Kim; E M Epner; W C Forrester; M Groudine
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

7.  Increased gamma-globin expression in a nondeletion HPFH mediated by an erythroid-specific DNA-binding factor.

Authors:  D I Martin; S F Tsai; S H Orkin
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

8.  Structure and promoter activity of the gene for the erythroid transcription factor GATA-1.

Authors:  R Hannon; T Evans; G Felsenfeld; H Gould
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

9.  Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells.

Authors:  S F Tsai; D I Martin; L I Zon; A D D'Andrea; G G Wong; S H Orkin
Journal:  Nature       Date:  1989-06-08       Impact factor: 49.962

10.  Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1.

Authors:  L Pevny; M C Simon; E Robertson; W H Klein; S F Tsai; V D'Agati; S H Orkin; F Costantini
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

View more
  86 in total

1.  Inositol polyphosphate 4-phosphatase type I regulates cell growth downstream of transcription factor GATA-1.

Authors:  P Vyas; F A Norris; R Joseph; P W Majerus; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice.

Authors:  M A McDevitt; Y Fujiwara; R A Shivdasani; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  A cell type-specific allele of the POU gene Oct-6 reveals Schwann cell autonomous function in nerve development and regeneration.

Authors:  Merhnaz Ghazvini; Wim Mandemakers; Martine Jaegle; Marko Piirsoo; Siska Driegen; Manousos Koutsourakis; Xsander Smit; Frank Grosveld; Dies Meijer
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

4.  The scl +18/19 stem cell enhancer is not required for hematopoiesis: identification of a 5' bifunctional hematopoietic-endothelial enhancer bound by Fli-1 and Elf-1.

Authors:  Berthold Göttgens; Cyril Broccardo; Maria-Jose Sanchez; Sophie Deveaux; George Murphy; Joachim R Göthert; Ekaterini Kotsopoulou; Sarah Kinston; Liz Delaney; Sandie Piltz; Linda M Barton; Kathy Knezevic; Wendy N Erber; C Glenn Begley; Jonathan Frampton; Anthony R Green
Journal:  Mol Cell Biol       Date:  2004-03       Impact factor: 4.272

5.  Quantitative trait locus on chromosome X affects bone loss after maturation in mice.

Authors:  Shuzo Okudaira; Motoyuki Shimizu; Bungo Otsuki; Rika Nakanishi; Akira Ohta; Keiichi Higuchi; Masanori Hosokawa; Tadao Tsuboyama; Takashi Nakamura
Journal:  J Bone Miner Metab       Date:  2010-03-31       Impact factor: 2.626

6.  PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure.

Authors:  Tomas Stopka; Derek F Amanatullah; Michael Papetti; Arthur I Skoultchi
Journal:  EMBO J       Date:  2005-10-13       Impact factor: 11.598

7.  Leukemogenesis caused by incapacitated GATA-1 function.

Authors:  Ritsuko Shimizu; Takashi Kuroha; Osamu Ohneda; Xiaoqing Pan; Kinuko Ohneda; Satoru Takahashi; Sjaak Philipsen; Masayuki Yamamoto
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

8.  Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.

Authors:  Zahra Kadri; Leila Maouche-Chretien; Heather M Rooke; Stuart H Orkin; Paul-Henri Romeo; Patrick Mayeux; Philippe Leboulch; Stany Chretien
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

9.  Haem-regulated eIF2alpha kinase is necessary for adaptive gene expression in erythroid precursors under the stress of iron deficiency.

Authors:  Sijin Liu; Sanchita Bhattacharya; Anping Han; Rajasekhar N V S Suragani; Wanting Zhao; Rebecca C Fry; Jane-Jane Chen
Journal:  Br J Haematol       Date:  2008-07-28       Impact factor: 6.998

10.  Rescue of the embryonic lethal hematopoietic defect reveals a critical role for GATA-2 in urogenital development.

Authors:  Y Zhou; K C Lim; K Onodera; S Takahashi; J Ohta; N Minegishi; F Y Tsai; S H Orkin; M Yamamoto; J D Engel
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.